The U.S. Securities and Exchange Commission issued a Risk Alert on September 14, 2026, targeting serious deficiencies in how registered investment advisers conduct their annual compliance reviews. The alert stems from the
Wall Street faces a demanding week ahead as investors navigate a Federal Reserve interest rate decision alongside a surge of high-profile corporate earnings reports. The convergence of monetary policy signals and major
More
Hargreaves Lansdown, one of the UK’s largest investment platforms, regularly publishes its weekly stock market preview to help investors prepare for key events. The weekly outlook is a widely followed guide among
More
Merck (NYSE: MRK) has unveiled a sweeping access strategy for alimatravir, an investigational once-monthly oral pill designed to prevent HIV-1 infection. The drug, also known as MK-8527, is being positioned as a
More
On July 23, President Trump issued a memorandum directing the U.S. Trade Representative to impose tariffs on goods from 60 economies found to have failed to ban imports made with forced labor.
More
Diageo (LSE: DGE) shares have endured a torrid few years, shedding more than half their value over the past three years alone. Despite that poor run, City analysts are now forecasting a
More
Alphabet and Tesla have long been considered bellwether stocks, their quarterly results often setting the tone for broader market sentiment across Wall Street. When two of the most closely watched companies in
More
Sponsorship expert Sarah Niblock argues that the scaled-down 2026 Commonwealth Games in Glasgow presents a rare and genuinely accessible opportunity for smaller brands. The 23rd Commonwealth Games is now under way in
More
On the second day of a two-day advisory meeting, FDA outside experts delivered their first rejection of the week, voting down emideltide for the 503A Bulk Drug Substances list. The FDA’s Pharmacy
More
The Supreme Court is facing renewed scrutiny over its relationship with the Trump administration, and Justice Elena Kagan is pushing back on critics who question the court’s independence. Speaking at a Ninth
More
WPP’s sweeping restructure under chief executive Cindy Rose is targeting £500 million in savings by 2028 through a plan known as Elevate28. Rose replaced Mark Read as CEO in October last year,
More